[HTML][HTML] An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud, M Poupart, P Ceruse… - BMC cancer, 2014 - Springer
Background The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
[HTML][HTML] An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud, M Poupart… - BMC Cancer, 2014 - ncbi.nlm.nih.gov
Background The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud, M Poupart… - BMC …, 2014 - pubmed.ncbi.nlm.nih.gov
Background The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
[PDF][PDF] An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud, M Poupart, P Ceruse… - 2014 - cyberleninka.org
Abstract Background: The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the
standard first-line regimen of recurrent and/or metastatic head and neck squamous cell …
standard first-line regimen of recurrent and/or metastatic head and neck squamous cell …
[PDF][PDF] An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud, M Poupart, P Ceruse… - 2014 - researchgate.net
Abstract Background: The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the
standard first-line regimen of recurrent and/or metastatic head and neck squamous cell …
standard first-line regimen of recurrent and/or metastatic head and neck squamous cell …
[HTML][HTML] An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud… - BMC …, 2014 - bmccancer.biomedcentral.com
The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard first-line
regimen of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) …
regimen of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) …
An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud, M Poupart… - BMC …, 2014 - univ-lyon1.hal.science
Background: The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents.
J Péron, V Polivka, S Chabaud, M Poupart, P Ceruse… - BMC Cancer, 2014 - europepmc.org
Background The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud, M Poupart, P Ceruse… - BMC Cancer, 2014 - hal.science
Background: The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
J Péron, V Polivka, S Chabaud, M Poupart… - BMC …, 2014 - search.proquest.com
Background: The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …
first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma …